Walgreens Boots Alliance Inc (WBA) : Partner Fund Management reduced its stake in Walgreens Boots Alliance Inc by 47.1% during the most recent quarter end. The investment management company now holds a total of 1,199,318 shares of Walgreens Boots Alliance Inc which is valued at $99,927,176 after selling 1,067,878 shares in Walgreens Boots Alliance Inc , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Walgreens Boots Alliance Inc makes up approximately 3.41% of Partner Fund Management’s portfolio.
Other Hedge Funds, Including , Landscape Capital Management L.l.c. reduced its stake in WBA by selling 3,417 shares or 49.94% in the most recent quarter. The Hedge Fund company now holds 3,425 shares of WBA which is valued at $285,371. Walgreens Boots Alliance Inc makes up approx 0.04% of Landscape Capital Management L.l.c.’s portfolio.Wilkins Investment Counsel Inc reduced its stake in WBA by selling 500 shares or 0.91% in the most recent quarter. The Hedge Fund company now holds 54,345 shares of WBA which is valued at $4,528,025. Walgreens Boots Alliance Inc makes up approx 1.22% of Wilkins Investment Counsel Inc’s portfolio.Brown Advisory Inc boosted its stake in WBA in the latest quarter, The investment management firm added 11,943 additional shares and now holds a total of 328,204 shares of Walgreens Boots Alliance Inc which is valued at $26,463,089. Walgreens Boots Alliance Inc makes up approx 0.09% of Brown Advisory Inc’s portfolio. Sivik Global Healthcare sold out all of its stake in WBA during the most recent quarter. The investment firm sold 70,000 shares of WBA which is valued $5,637,100.
Walgreens Boots Alliance Inc opened for trading at $81.04 and hit $81.71 on the upside on Thursday, eventually ending the session at $81.54, with a gain of 1.03% or 0.83 points. The heightened volatility saw the trading volume jump to 32,96,108 shares. Company has a market cap of $88,252 M.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Company shares were Reiterated by Deutsche Bank on Aug 30, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $93 .Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90 .Walgreens Boots Alliance Inc was Resumed by BofA/Merrill to “Buy” on Jun 7, 2016.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.